{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:07:08Z","timestamp":1792829228958,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omtn.2025.102757","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:10:30Z","timestamp":1761869430000},"page":"102757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["SCAD: A modular platform for efficient delivery of duplex RNA to the CNS and beyond"],"prefix":"10.1016","volume":"36","author":[{"given":"Moorim","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Schacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubao","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3971-6335","authenticated-orcid":false,"given":"Long-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102757_bib1","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1111\/bph.15972","article-title":"Small interfering RNA: Discovery, pharmacology and clinical development-An introductory review","volume":"180","author":"Ranasinghe","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.omtn.2025.102757_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113834","article-title":"Nucleic acid delivery for therapeutic applications","volume":"178","author":"Gupta","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2025.102757_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: considerations and future directions","volume":"23","author":"Tang","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102757_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11095-022-03433-5","article-title":"CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood-Brain Barrier and Towards Specific Cellular Targeting","volume":"40","author":"D'Souza","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.omtn.2025.102757_bib5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102757_bib6","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","article-title":"Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates","volume":"40","author":"Brown","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102757_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119455","article-title":"Peptide-Based Nanoparticles for Systemic Extrahepatic Delivery of Therapeutic Nucleotides","volume":"24","author":"Wickline","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102757_bib8","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/mp200250f","article-title":"Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity","volume":"8","author":"Kubo","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtn.2025.102757_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf600","article-title":"Elucidating brain transport pathways and cell type-dependent gene silencing of a durable lipid-siRNA conjugate administered into cerebrospinal fluid","volume":"53","author":"Sorets","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102757_bib10","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1016\/j.ymthe.2025.05.010","article-title":"RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS mice","volume":"33","author":"Weiss","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102757_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi2245","article-title":"Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier","volume":"16","author":"Barker","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2025.102757_bib12","doi-asserted-by":"crossref","first-page":"183ra57","DOI":"10.1126\/scitranslmed.3005338","article-title":"Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier","volume":"5","author":"Couch","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2025.102757_bib13","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40265-023-01904-6","article-title":"Tofersen: First Approval","volume":"83","author":"Blair","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.omtn.2025.102757_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2025.102757_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000517686","article-title":"Antisense Oligonucleotide Therapy for Neurodevelopmental Disorders","volume":"43","author":"Hill","year":"2021","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.omtn.2025.102757_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112389","article-title":"Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology","volume":"14","author":"Amanat","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2025.102757_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/nat.2014.0506","article-title":"Phosphorothioates, essential components of therapeutic oligonucleotides","volume":"24","author":"Eckstein","year":"2014","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2025.102757_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular uptake and trafficking of antisense oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102757_bib19","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1172\/JCI99081","article-title":"Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models","volume":"128","author":"McCampbell","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2025.102757_bib20","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1093\/nar\/gkaa299","article-title":"Phosphorothioate modified oligonucleotide-protein interactions","volume":"48","author":"Crooke","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102757_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/nat.2023.0056","article-title":"Sequence- and Structure-Dependent Cytotoxicity of Phosphorothioate and 2'-O-Methyl Modified Single-Stranded Oligonucleotides","volume":"34","author":"Croft","year":"2024","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2025.102757_bib22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/nar\/gkab544","article-title":"Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivo","volume":"50","author":"Jahns","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102757_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102147","article-title":"Intrathecal administration of a novel siRNA modality extends survival and improves motor function in the SOD1(G93A) ALS mouse model","volume":"35","author":"Duan","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102757_bib24","article-title":"RAG-17: A Novel siRNA Conjugate Demonstrating Efficacy in Late-Stage Treatment of SOD1G93A ALS mice","author":"Duan","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2025.102757_bib25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41587-019-0205-0","article-title":"A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system","volume":"37","author":"Alterman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102757_bib26","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1093\/nar\/gkae368","article-title":"A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system","volume":"52","author":"Belgrad","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102757_bib27","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/cpph.43","article-title":"The Irwin Test and Functional Observational Battery (FOB) for Assessing the Effects of Compounds on Behavior, Physiology, and Safety Pharmacology in Rodents","volume":"83","author":"Mathiasen","year":"2018","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.omtn.2025.102757_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/faat.1997.2388","article-title":"EPA's neurotoxicity risk assessment guidelines","volume":"40","author":"Boyes","year":"1997","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.omtn.2025.102757_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102080","article-title":"Dendritic amphiphilic siRNA: Selective albumin binding, in vivo efficacy, and low toxicity","volume":"34","author":"Fakih","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102757_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41582-021-00487-8","article-title":"Non-neuronal cells in amyotrophic lateral sclerosis - from pathogenesis to biomarkers","volume":"17","author":"Vahsen","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtn.2025.102757_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101312","article-title":"Combination AAV therapy with galectin-1 and SOD1 downregulation demonstrates superior therapeutic effect in a severe ALS mouse model","volume":"32","author":"Baird","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102757_bib32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cell.2011.10.011","article-title":"The seeds of neurodegeneration: prion-like spreading in ALS","volume":"147","author":"Polymenidou","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2025.102757_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boillee","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2025.102757_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtn.2025.102757_bib35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nn1885","article-title":"Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model","volume":"10","author":"Di Giorgio","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtn.2025.102757_bib36","unstructured":"ALZFORUM: https:\/\/www.alzforum.org\/therapeutics\/mivelsiran."},{"key":"10.1016\/j.omtn.2025.102757_bib37","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1212\/WNL.0000000000212372","article-title":"RAG-17, a Novel siRNA Therapy for SOD1-ALS: Safety and Preliminary Efficacy from a First-in-human Trial (S5.003)","volume":"104","author":"Ye","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2025.102757_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100086","article-title":"Protocol for Primary Mouse Hepatocyte Isolation","volume":"1","author":"Charni-Natan","year":"2020","journal-title":"STAR Protoc."},{"key":"10.1016\/j.omtn.2025.102757_bib39","article-title":"Non-invasive Intratracheal Instillation in Mice","volume":"5","author":"Ortiz-Munoz","year":"2015","journal-title":"Bio Protoc"},{"key":"10.1016\/j.omtn.2025.102757_bib40","article-title":"Intravitreous injection for establishing ocular diseases model","volume":"313","author":"Chiu","year":"2007","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omtn.2025.102757_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/ar4436","article-title":"Intra-articular injection of collagenase in the knee of rats as an alternative model to study nociception associated with osteoarthritis","volume":"16","author":"Adaes","year":"2014","journal-title":"Arthritis Res. Ther."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T02:07:18Z","timestamp":1766196438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125003117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2162253125003117"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102757","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SCAD: A modular platform for efficient delivery of duplex RNA to the CNS and beyond","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102757"}}